JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation
Phase 1/2 Completed
29 enrolled
Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors
Phase 1/2 Completed
44 enrolled 22 charts
A Study of GFH925 in Combination With Cetuximab in Previously Untreated Advanced NSCLC Harboring KRAS G12C Mutation
Phase 1/2 Completed
47 enrolled
GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors
Phase 1/2 Completed
26 enrolled 47 charts
AFACET
Phase 2 Completed
37 enrolled
Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer
Phase 2 Completed
72 enrolled 9 charts
Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung Cancer
Phase 1/2 Completed
7 enrolled
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
Phase 1 Completed
210 enrolled
ACE-Lung
Phase 2 Completed
118 enrolled
High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase 3 Completed
544 enrolled 21 charts
Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC
Phase 2 Completed
43 enrolled 18 charts
Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)
Phase 2 Completed
69 enrolled
Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)
Phase 2 Completed
106 enrolled 13 charts
Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer
Phase 1/2 Completed
30 enrolled
A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before
Phase 2 Completed
64 enrolled 20 charts
Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
37 enrolled
Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer
Phase 1/2 Completed
64 enrolled 11 charts
MesoMab
Phase 2 Completed
22 enrolled
CERTO
Phase 2 Completed
232 enrolled 17 charts
Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer
Phase 2 Completed
90 enrolled 20 charts
Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer
Phase 2 Completed
109 enrolled 12 charts
Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer
Phase 1/2 Completed
36 enrolled 12 charts
A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
Phase 1 Completed
48 enrolled 14 charts
Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
Phase 2 Completed
58 enrolled 8 charts
Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer
Phase 3 Completed
755 enrolled 26 charts
Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer
Phase 2 Completed
72 enrolled 15 charts
Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer
Phase 2 Completed
Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer
Phase 2 Completed
120 enrolled
A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer
Phase 1 Completed
30 enrolled
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma
Phase 1 Completed
120 enrolled
Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC)
Phase 2 Completed
27 enrolled 8 charts
Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer
Phase 1 Completed
171 enrolled 23 charts
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
Phase 1 Completed
43 enrolled
S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase 2 Completed
110 enrolled 8 charts
A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer
Phase 2 Completed
113 enrolled 14 charts
Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung Cancer
Phase 2 Completed
140 enrolled 9 charts
FLEX
Phase 3 Completed
1,861 enrolled 15 charts
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer
Phase 1/2 Completed
66 enrolled
NEXT
Phase 3 Completed
583 enrolled 15 charts
Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)
Phase 2 Completed
41 enrolled
Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Phase 2 Completed
62 enrolled
Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer
Phase 2 Completed
69 enrolled 9 charts
S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 2 Completed
242 enrolled
Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
Phase 3 Completed
939 enrolled 21 charts
CALC-1
Phase 2 Completed
100 enrolled
Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Phase 2 Completed
30 enrolled
Phase I Cetuximab and Concurrent Radio-chemotherapy
Phase 1 Completed
24 enrolled
Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer
Phase 2 Completed
53 enrolled
Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer
Phase 2 Completed
66 enrolled
Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer
Phase 1/2 Completed
32 enrolled